Walleye Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-699,621	Closed	-$3.63M	–	5776
2024 Q3	$3.63M	Buy	699,621 +88,829	+15%	+$441K	0.01%	1418
2024 Q2	$1.57M	Sell	610,792 -11,334	-2%	-$38.7K	﹤0.01%	2346
2024 Q1	$3.06M	Sell	622,126 -305,688	-33%	-$1.81M	0.01%	1675
2023 Q4	$8.16M	Buy	927,814 +622,022	+203%	+$5.1M	0.02%	794
2023 Q3	$3.51M	Buy	305,792 +192,004	+169%	+$3.69M	0.01%	1298
2023 Q2	$2.88M	Sell	113,788 -166,574	-59%	-$5.19M	0.01%	1074
2023 Q1	$9.03M	Sell	280,362 -228,333	-45%	-$7.12M	0.14%	165
2022 Q4	$9.39M	Sell	508,695 -14,350	-3%	-$328K	0.17%	134
2022 Q3	$14.1M	Buy	523,045 +58,075	+12%	+$1.18M	0.27%	58
2022 Q2	$6.43M	Sell	464,970 -40,731	-8%	-$627K	0.18%	131
2022 Q1	$9.86M	Buy	505,701 +148,464	+42%	+$2.25M	0.26%	79
2021 Q4	$5.83M	Buy	357,237 +302,760	+556%	+$5.05M	0.18%	119
2021 Q3	$1.52K	Sell	54,477 -52,382	-49%	-$1.49M	0.04%	298
2021 Q2	$3.17K	Buy	106,859 +36,610	+52%	+$1.06M	0.11%	156
2021 Q1	$1.96K	Sell	70,249 -1,116	-2%	-$30.9K	0.11%	151
2020 Q4	$2.02K	Buy	+71,365	New	+$1.85M	0.14%	123
2018 Q3	$438K	Buy	+17,644	New	+$480K	0.2%	142